loading animation for AJAX calls

178 Reports in Pharmaceuticals

Skin Disease Treatment Technologies and Global Markets

Published - Jan 2016 | Analyst - Paul Evers| Code - PHM127B

The global market for skin disease treatment technologies reached $16.4 billion in 2014 and $17.1 billion in 2015. The market should reach $20.4 billion in 2020, demonstrating a compound annual growth rate (CAGR) of 3.6% from 2015 to 2020.

Global Markets for Infectious Disease Treatments

Published - Jan 2016 | Analyst - Peggy Lehr| Code - PHM061C

The global market for infectious disease diagnostic, vaccine, and treatment products reached $108.4 billion in 2015. The market should reach $126.2 billion in 2016 and $183.2 billion in 2021, demonstrating a compound annual growth rate (CAGR) of 7.7% from 2016 to 2021.

Erythropoietin Stimulating Agents: Therapeutic Applications and G...

Published - Jan 2016 | Analyst - Aneesh Kumar| Code - PHM130A

The global market for erythropoietin stimulating agents (ESAs) will grow from nearly $7.2 billion in 2015 to nearly $7.3 billion by 2020 with a compound annual growth rate (CAGR) of 0.2% for the period 2015-2020.

Global Markets for Orphan Drugs

Published - Sep 2015 | Analyst - Shalini Shahani Dewan| Code - PHM038E

The global orphan drug market totaled nearly $123 billion in 2014 and will continue to grow to reach nearly $191 billion by 2019, demonstrating a compound annual growth rate (CAGR) of 9.2% during the forecast period (2014 to 2019).

Ophthalmic Therapeutic Drugs: Technologies and Global Markets

Published - Jul 2015 | Analyst - Dr. Cheryl Lee Barton| Code - PHM031D

The global ophthalmic therapeutic drug market was valued at $12.3 billion in 2014. This market is expected to reach $19 billion by 2019, with a compound annual growth rate (CAGR) of 9.1% from 2014 to 2019.

Global Markets for Contract Pharmaceutical Manufacturing, Researc...

Published - Jun 2015 | Analyst - Shalini Shahani Dewan| Code - PHM043F

The global market for contract pharmaceutical manufacturing, research and packaging totaled $248.5 billion in 2014 and is projected to approach $352.8 billion by 2019, registering a compound annual growth rate (CAGR) of 7.3% through 2019.

Liver Disease Treatments: The Global Market

Published - Jun 2015 | Analyst - Yogita Zutshi| Code - PHM057C

The global liver diseases therapeutics market totaled nearly $24.5 billion in 2014 and is projected to approach $33.8 billion by 2019, registering a compound annual growth rate (CAGR) of 6.7% through 2019.

Diagnostics and Therapeutics for Lung Cancer: Global Markets

Published - May 2015 | Analyst - Vijay Laxmi| Code - PHM174A

The global market for lung cancer grew to $21.9 billion in 2014 from $20.3 billion in 2013. The market is expected to grow at a five-year compound annual growth rate (CAGR) of 7.8% from 2014 to 2019, totaling $31.8 billion in 2019.

Regenerative Medicines: Bone and Joint Applications

Published - May 2015 | Analyst - Kevin Gainer| Code - PHM032D

The U.S. market for regenerative medicine products used in bone and joint applications is expected to grow at a compound annual growth rate (CAGR) of 6.8% from $2.9 billion in 2015 to nearly $4.1 billion in 2020.

Drug Testing: Technologies and Global Markets

Published - Mar 2015 | Analyst - Jon Evans| Code - PHM013F

The global drug of abuse (DOA) testing market reached nearly $2.8 billion in 2014. This market is estimated to grow at a compound annual growth rate (CAGR) of 4.5% to reach almost $3.5 billion by 2019.

Incretin-Based Drugs: Markets for Diabetes Therapies and Developi...

Published - Feb 2015 | Analyst - Kim Lawson| Code - PHM162A

The global market for incretin-based therapeutics was valued at nearly $11.8 billion in 2013 and $12.7 billion in 2014. This market is expected to reach $22.8 billion by 2019, with a compound annual growth rate (CAGR) of 12.4% from 2014 to 2019.

Therapeutics for 'Silent' Cancers

Published - Feb 2015 | Analyst - Paul Evers| Code - PHM169A

The global market for “silent” cancers was valued at $8.5 billion in 2013 and $9 billion in 2014. This market is expected to reach almost $13.6 billion by 2019, with a compound annual growth rate (CAGR) of 8.5% from 2014 to 2019.

Global Markets for Allergy Diagnostics and Treatments

Published - Feb 2015 | Analyst - Peggy Lehr| Code - PHM026B

Global allergy diagnostic and treatment market is projected to increase to nearly $35.3 billion by 2015 from $31.5 billion in 2014. This market is expected to reach $46.8 billion by 2020, corresponding to a compound annual growth rate (CAGR) of 5.8% during 2015 to 2020 period.

Global Markets for Drug-Device Combinations

Published - Jan 2015 | Analyst - Kevin Gainer| Code - PHM045D

The sales of drug-device combination products reached $21.4 billion in 2013 and $22 billion in 2014. This market is expected to grow to $31 billion in 2019, with a compound annual growth rate (CAGR) of 7.1% from 2014 to 2019.

Cancer Vaccines: Technologies and Global Markets

Published - Jan 2015 | Analyst - Shalini Shahani Dewan| Code - PHM173A

The global market for cancer vaccines was about $4.5 billion in 2013. This market reached about $4.0 billion in 2014 and is expected to reach $4.3 billion in 2019, registering a compound annual growth rate (CAGR) of 1.3% for the period 2014-2019.

Pediatric Medicines: Global Markets

Published - Oct 2014 | Analyst - Dr. Cheryl Lee Barton| Code - PHM170A

The global market for pediatric medicines reached $80.7 billion in 2013 and should reach $83.6 billion in 2014. This market is expected to reach about $100.7 billion by 2019, registering a compound annual growth rate (CAGR) of 3.8% from 2014 to 2019.

Radiopharmaceuticals: Technologies and Global Markets

Published - Sep 2014 | Analyst - Shalini Shahani Dewan| Code - PHM171A

The global market for radiopharmaceuticals in 2012 was about $3.8 billion and $3.9 billion in 2013. The estimated market for the year 2014 is nearly $4.4 billion and this figure is forecast to expand through 2019 at a projected compound annual growth rate (CAGR) of 8%, approaching $6.4 billion.

Autoimmune Disease Diagnostics: Global Markets

Published - Sep 2014 | Analyst - Anandi Karumbati| Code - PHM160A

The global market value for autoimmune disease diagnostics for 2013 was valued at $11.9 billion. This is expected to reach about $12.1 billion in 2014 and $13.1 billion in 2019, with a compound annual growth rate (CAGR) of 1.6% for the five-year period, 2014 to 2019.

Blood-Brain Barrier Technologies and Global Markets

Published - Jul 2014 | Analyst - Kim Lawson| Code - PHM075B

The global market for blood-brain barrier (BBB) technology for therapeutics reached $21.8 million in 2013. This market is expected to grow from $38.7 million in 2014 to $471.5 million in 2019, a compound annual growth rate (CAGR) of 64.9% from 2014 through 2019.

Multiple Sclerosis (MS) Drugs and Biologics: Technologies and Glo...

Published - Jun 2014 | Analyst - Yogita Zutshi| Code - PHM069B

The global market for Multiple Sclerosis (MS) disease-modifying products reached $10.1 billion in 2012 and nearly $10.9 billion in 2013. This market is expected to grow to nearly $14.2 billion in 2018 with a compound annual growth rate (CAGR) of 5.4% over the five-year period from 2013 to 2018.

Antifungal Drugs: Technologies and Global Markets

Published - Jun 2014 | Analyst - Mary Anne Crandall| Code - PHM029E

The global market for human antifungal therapeutics reached nearly $11.6 billion in 2012 and $11.8 billion in 2013. This market is expected to grow to nearly $13.9 billion in 2018 with a compound annual growth rate (CAGR) of 3.2% over the five-year period from 2013 to 2018.

Markets for Advanced Wound Management Technologies

Published - Jun 2014 | Analyst - Melissa Elder| Code - PHM011H

The global market for advanced wound management totaled $8.6 billion in 2013, up from 2011’s value of $7.9 billion. By 2018, this market is likely to reach $11.3 billion, a compound annual growth rate (CAGR) of 5.6%.

Antibiotics: Technologies and Global Markets

Published - May 2014 | Analyst - Neha Maliwal| Code - PHM025C

The global systemic antibiotics market was valued at $39.6 billion in 2013 and is expected to reach $41.2 billion by 2018, at a CAGR of 0.8%.

JAK and PI3K Signaling Pathway Markets

Published - Apr 2014 | Analyst - Shalini Shahani Dewan| Code - PHM168A

The global market for signal transduction therapies/inhibitors (JAK and PI3K) reached $173.5 million in 2012. This market is expected to grow to $464.5 million in 2013 and $2.2 billion in 2018 with a compound annual growth rate (CAGR) of 36.8% over the five-year period from 2013 to 2018.

Diagnostics and Therapeutics for HIV: Global Markets

Published - Apr 2014 | Analyst - Kritika Chaudhari| Code - PHM058B

The global market for HIV therapeutics is expected to grow to $18.2 billion in 2013 and $19.6 in 2018, with a compound annual growth rate (CAGR) of 1.5%.

« 2 3 4 5 6 »

2 Upcoming Reports in Pharmaceuticals

Communicable Disease Market: A BCC Research Overview

Target Date - Jul 2019| Author - BCC Research Staff| Code - PHM216A| Price - $5,500

This report provides market size estimates and forecasts for the global market and all major market segments through 2024.

Report Includes
  • Detailed overview of the global market for communicable diseases within the healthcare industry
  • Analyses of the global market trends, with data from 2018, estimates for 2019, and projections of compound annual growth rates (CAGRs) through 2024
  • Regional analysis of the communicable disease market, covering North America, Europe, Asia-Pacific and rest of the world
  • A look at the government regulations pertaining to drug developments for communicable diseases and pipeline analysis covering ongoing clinical trials and promising forthcoming therapies in late stage
  • Discussion of competitive landscape, mergers and acquisitions of companies to enhance their product portfolio, and future commercial marketplace
  • Comprehensive company profiles of major market players

Continuous Manufacturing in Pharmaceuticals: Implications for the Generics Market

Target Date - Jul 2019| Author - Kamna Jhamb| Code - PHM214A| Price - $2,500

Get an introduction to continuous manufacturing (CM) and identification of its applications along with the latest trends and technologies in CM as compared to generic drugs market.

 
Get Notified when New Reports are published
MEMBERSHIP

 

CUSTOM